共 298 条
[1]
Gao Q(2020)Development of an inactivated vaccine candidate for SARS-CoV-2 Science 369 77-81
[2]
Bao L(2021)Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial Lancet Infect Dis 21 181-192
[3]
Mao H(2021)Interim report: safety and immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy chilean adults in a phase 3 clinical trial medRxiv 397 671-681
[4]
Wang L(2021)American College of Rheumatology Guidance for COVID-19 vaccination in patients with rheumatic and musculoskeletal diseases-Version 1 Arthritis Rheumatol 383 2603-2615
[5]
Xu K(2021)Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia Lancet 17 71-72
[6]
Yang M(2020)Safety and efficacy of the BNT162b2 mRNA Covid-19 Vaccine N Engl J Med 7 240-243
[7]
Li Y(2021)Rheumatic disease and COVID- 19: epidemiology and outcomes Nat Rev Rheumatol 36 e95-1786
[8]
Zhu L(2020)Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: a comprehensive systematic review and meta-analysis of 77 studies and 38,000 patients PLoS ONE 325 1784-353
[9]
Wang N(2018)Age-adjusted charlson comorbidity index and 30-day morbidity in pelvic surgeries South Asian J Cancer. S0085–2538 00348-S89
[10]
Lv Z(2021)Performance evaluation of the Roche Elecsys Anti-SARS-CoV-2 immunoassay medRxiv 30 S83-625